Kyri van Hoose
Director of Finance/CFO at DERMATA THERAPEUTICS, INC.
Net worth: - $ as of 2024-05-30
Kyri van Hoose active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TURG POIN | Comptroller/Controller/Auditor | 2021-05-04 | - |
| DERMATA THERAPEUTICS, INC. | Director of Finance/CFO | 2021-08-31 | - |
Career history of Kyri van Hoose
Former positions of Kyri van Hoose
| Companies | Position | Start | End |
|---|---|---|---|
TEGA Therapeutics, Inc.
 TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Director of Finance/CFO | 2020-08-31 | 2021-04-29 |
Curzion Pharmaceuticals, Inc.
 Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 2019-10-31 | 2020-03-31 |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Director of Finance/CFO | 2017-11-30 | 2019-06-30 |
| ACADIA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 2005-08-31 | 2016-01-31 |
Training of Kyri van Hoose
| University of Southern California | Undergraduate Degree |
| University of California, Irvine | Masters Business Admin |
Statistics
International
| United States | 9 |
Operational
| Director of Finance/CFO | 3 |
| Comptroller/Controller/Auditor | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| DERMATA THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Health Services |
Curzion Pharmaceuticals, Inc.
Curzion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curzion Pharmaceuticals, Inc. operates as a pharmaceutical firm. The company is headquartered in San Diego, CA. | Health Technology |
TEGA Therapeutics, Inc.
TEGA Therapeutics, Inc. BiotechnologyHealth Technology TEGA Therapeutics, Inc. produces recombinant heparan sulfate and enzyme replacement therapies for lysosomal storage diseases. The company is based in San Diego, CA. Glass, Jeffrey D. Esko. TEGA Therapeutics was founded by Yitzhak Tor, Timothy Scott, Charles A. Timothy Scott has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Kyri van Hoose
- Experience
